M Laplante, WT Festuccia, G Soucy, Y … - Diabetes, 2006 - Am Diabetes Assoc In this study, we aimed to establish the mechanisms whereby peroxisome
proliferator–activated receptor γ (PPARγ) agonism brings about
redistribution of fat toward subcutaneous depots and away from visceral ... Cited by 42 - Related articles - BL Direct - All 4 versions
M Laplante, WT Festuccia, G Soucy, Y Gelinas … - 糖尿病学杂志, 2006 - journal.shouxi.net In this study, we aimed to establish the mechanisms whereby peroxisome
proliferator activated receptor (PPAR) agonism brings about redistribution of
fat toward subcutaneous depots and away from visceral fat. In rats treated ... Related articles - Cached
WT Festuccia, M Laplante, M Berthiaume, Y … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis The aim of this study was to investigate the effect and
mechanisms of action of in vivo peroxisome proliferator-activated receptor γ
(PPARγ) activation on white adipose tissue (WAT) lipolysis and NEFA ... Cited by 30 - Related articles - BL Direct - All 4 versions
P Domingo, F Vidal, JC Domingo, S Veloso, MA … - European journal of clinical investigation, 2005 - pt.wkhealth.com Department of Internal Medicine (Infectious Diseases Unit) (P. Domingo, MA
Sambeat), Hospital de la Santa Creu i Sant Pau, Biostatistics Laboratory (F.
Torres), Autonomous University of Barcelona, Barcelona; Department of ... Cited by 21 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org M Laplante, H Sell, KL MacNaul, D Richard, … - Diabetes, 2003 - Am Diabetes Assoc This study sought to determine whether the adipose depot−specific
(subcutaneous [SF] vs. visceral [VF]) action of peroxisome
proliferator−activated receptor-γ (PPAR-γ) agonists on fat deposition ... Cited by 77 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org G Boden, C Homko, M Mozzoli, LC Showe, C … - Diabetes, 2005 - Am Diabetes Assoc Thiazolidinediones (TZDs) are a new class of insulin-sensitizing drugs. To
explore how and in which tissues they improve insulin action, we obtained fat
and muscle biopsies from eight patients with type 2 diabetes before and 2 ... Cited by 53 - Related articles - All 5 versions
EH Koh, JY Park, HS Park, MJ Jeon, JW Ryu, … - Diabetes, 2007 - Am Diabetes Assoc RESULTS—Adiponectin expression and mitochondrial content in adipose tissue
were reduced in obese db/db mice, and these changes were reversed by the
administration of rosiglitazone. In cultured adipocytes, induction of ... Cited by 16 - Related articles - BL Direct - All 4 versions
SR Smith, L de Jonge, J Volaufova, Y Li, H … - Metabolism, 2005 - Elsevier We performed a randomized, double-blind, placebo-controlled trial in 48 men and
women with type 2 diabetes who had not previously received treatment with TZDs.
Patients were treated for 24 weeks with 45 mg/d of pioglitazone or a ... Cited by 68 - Related articles - All 9 versions
- ►endojournals.org P Fischer-Posovszky, H Hebestreit, AK … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Results: Analysis of adipose tissue samples of the patient with acquired
lipodystrophy obtained from skin areas affected by panniculitis suggested that
loss of adipocytes was mediated by CD95-induced apoptosis. Regression of ... Cited by 5 - Related articles - BL Direct - All 4 versions
Y Wang, PY Wang, K Takashi - Endocrine, 2006 - Springer Received July 26, 2005; Revised October 30, 2005; Accepted November 3, 2005.
Author to whom all correspondence and reprint requests should be addressed: Yuan
Wang, MD, Department of Endocrinology, The 4th Affiliated Hospi- tal, HeBei ... Cited by 5 - Related articles - BL Direct - All 3 versions
